Stay updated on Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial
Sign up to get notified when there's something new on the Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial page.

Latest updates to the Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial page
- Check2 days agoChange DetectedNew study locations have been added across the United States, Australia, and Canada and several existing sites have been removed, including the HHS Vulnerability Disclosure; the page revision is v3.3.3.SummaryDifference2%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedPublications section updated to indicate PubMed entries are auto-filled and may not be about the study, and the revision version was updated to v3.3.2.SummaryDifference0.1%

- Check38 days agoChange DetectedThe government funding notice banner at the top of the page has been removed.SummaryDifference0.3%

- Check52 days agoChange DetectedTwo screenshots show no meaningful edits to the Study Details page (NCT03703882). Core content including eligibility criteria, study design, outcomes, and listed locations remains unchanged.SummaryDifference0.3%

- Check81 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference3%

- Check88 days agoChange DetectedUpdate to version v3.1.0 with removal of several drug-safety topics; indicates content reorganization/revision rather than new substantive additions.SummaryDifference0.4%

Stay in the know with updates to Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Edasalonexent in Duchenne Muscular Dystrophy Clinical Trial page.